Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service

Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, today announced it has received notification from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) that the Company is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme, and is, therefore, able to offer GLP compliant hERG ion channel screening services to the global life sciences community.

US government OK with combining suits from Bristol Myers, J&J in IRA fight

Bristol Myers Squibb, Johnson & Johnson and the US government agreed that the two companies can consolidate their briefs together in their cases against the

August 1, 2023

Senators want to know more on why Novo is discontinuing its insulin Levemir

Novo Nordisk decided to discontinue its long-acting insulin Levemir last November, and three Democrats in the Senate want to know why, laying out their questions

April 20, 2024

New research highlights barriers to helmet use among cyclists

Wearing a helmet can prevent brain injury and deaths in cyclists, yet many do not wear a helmet. New research presented at the European Emergency

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.